EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

FT15 - The Heterogenicity of asthma

Sunday 15 Jun, 09:00 AM - 10:30 AM Glasgow, United Kingdom
Dochart 2 Flash Talks
09:00
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease
09:07
Clinical Effectiveness of Tezepelumab on Upper and Lower Airway Symptoms in Patients with Asthma and Co-morbid Nasal Polyposis
09:14
Dupilumab alleviates the abnormal differentiation of club cells induced by IL-13 in chronic rhinosinusitis with nasal polyps
09:21
Alterations in cell-cell contacts are relevant for bradykinin-mediated endothelial barrier disruption
09:28
The effect of brief and sustained hypoxic conditions on immunological properties of Human Lung Microvascular Endothelium
09:35
CD62L blockade may affect the activity of the eosinophil
09:42
Association between Blood Eosinophil Counts, Nasal Cytology, and Serum Inflammatory Biomarkers in Patients with Severe Asthma. The BRISA STUDY
09:49
Long-term Qipian® administration prevents airway inflammation in ovalbumin-induced mouse asthma via restoring Th1/Th2 balance and modulating gut microbiota
09:56
Elevated Fucosylation and the Role of Fut1 in Asthma: A Key Contributor to Abnormal Glycosylation in Airway Epithelial Cells
10:03
Challenges for transitional care for adolescents and young adults with asthma - from the healthcare professionals’ perspectives
10:10
Multicohort Analysis Profiles the Blood-Based Transcriptome Features of Adult and Childhood Asthma

Chairs

Speakers